Boviseal is licensed for the prevention of new intramammary infections throughout the dry period. This results in a reduction in the incidence of subclinical mastitis in the dry period and the subsequent lactation (for at least 60 days after calving).
Infusion of Boviseal into each udder quarter produces a seal in the teat that provides an immediate and long lasting physical barrier to entry of bacteria and other mastitis causing organisms.
Click here to find out more about #SealingTheFuture
Package Quantities: Buckets of 120 single dose intramammary syringes
Presentation: Grey to white coloured cream containing Bismuth subnitrate 2.6 g per syringe. Also contains liquid paraffin, alumium di tri-stearate and colloidal anydrous silica.
Withdrawal: zero days
LegalCategory: LM VPA Number:10387/096/001
Summary of Product Characteristics: Full product licence here
